<DOC>
	<DOCNO>NCT00880711</DOCNO>
	<brief_summary>The purpose collect real life data use fulvestrant normal clinical practice Austria document clinical benefit fulvestrant treatment .</brief_summary>
	<brief_title>Faslodex International Observational Non-Interventional Study Advanced Breast Cancer ( BC )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<criteria>Postmenopausal woman hormone receptorpositive locally advanced metastatic breast cancer Ability read write complete questionnaire Provision write informed consent Patients already receive prescription fulvestrant A subject fulfil mention inclusion criterion allow participate NIS</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Fiona</keyword>
	<keyword>Faslodex</keyword>
	<keyword>Advanced Breast Cancer</keyword>
	<keyword>Real life data</keyword>
	<keyword>Collect real life data clinical practice across Austria</keyword>
</DOC>